分類彙整: 減肥減重

Smaller meals, slower eating, lower-fat foods, and hydration may reduce nausea for some patients.

Nausea, constipation, diarrhea, and reflux are common and often improve with eating adjustments and dose guidance.

Both medicines can support weight management, but they differ in mechanisms, response, tolerability, and prescribing decisions.

Tirzepatide may produce meaningful weight loss for eligible patients but requires individualized monitoring.

Semaglutide may help eligible patients lose weight when combined with nutrition, activity, and follow-up.

Dual incretin medicines such as tirzepatide act on appetite and metabolic pathways and require medical supervision.

GLP-1 medicines can reduce appetite, increase fullness, and support weight loss for appropriate patients.

Medication works best when paired with nutrition, activity, sleep, behavior skills, and medical follow-up.

Medication may be considered when weight-related health risks remain despite structured lifestyle treatment.

Mood, anxiety, sleep, appetite, and body image can all affect weight care and deserve attention.